Patients with diabetic ketoacidosis (DKA) can benefit from using a continuous glucose monitor (CGM) due to their ability to provide accurate blood glucose measurements and identify missed opportunities for earlier intervention, according to data published in the journal CHEST Critical Care.1 Authors of the study said that future trials should assess the impact of CGM on patient outcomes, experiences, and resource use.
CGM Could Help Management of Diabetic Ketoacidosis / sudok1 – stock.adobe.com
DKA is a life-threatening complication of diabetes and is typically seen in patients with type 1 diabetes (T1D).2 There are numerous triggers for DKA, including new-onset diabetes, infections, or lack of compliance with treatment. Although the mortality rate of DKA is low—between 0.2% and 2.5%—complications can include…